• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Mehra Golshan, MD


  • Tolaney SM, Jeong J, Guo H, Brock J, Morganstern D, Come SE, Golshan M, Bellon J, Winer EP, Krop IE.A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer.Cancer Med. 2014 Apr;3(2):293-9.
  • Bunnell CA, Losk K, Kadish S, Lin N, Hirshfield-Bartek J, Cutone L, Camuso K, Golshan M, Weingart S.Measuring opportunities to improve timeliness of breast cancer care at Dana-Farber/Brigham and Women's Cancer Center.J Natl Compr Canc Netw. 2014 Feb;12 Suppl 1:S5-9.
  • Camp MS, Valero MG, Opara N, Benabou K, Cutone L, Caragacianu D, Dominici L, Golshan M.Intraoperative digital specimen mammography: a significant improvement in operative efficiency.Am J Surg. 2013 Oct;206(4):526-9.
  • Kansal KJ, Dominici LS, Tolaney SM, Isakoff SJ, Smith BL, Jiang W, Brock JE, Winer EP, Krop IE, Golshan M.Neoadjuvant bevacizumab: surgical complications of mastectomy with and without reconstruction.Breast Cancer Res Treat. 2013 Sep;141(2):255-9.
  • Russo AL, Arvold ND, Niemierko A, Wong N, Wong JS, Bellon JR, Punglia RS, Golshan M, Troyan SL, Brock JE, Harris JR.Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.Breast Cancer Res Treat. 2013 Jul;140(2):353-61.
  • Toi M, Benson JR, Winer EP, Forbes JF, von Minckwitz G, Golshan M, Robertson JF, Sasano H, Cole BF, Chow LW, Pegram MD, Han W, Huang CS, Ikeda T, Kanao S, Lee ES, Noguchi S, Ohno S, Partridge AH, Rouzier R, Tozaki M, Sugie T, Yamauchi A, Inamoto T.Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference.Breast Cancer Res Treat. 2012 Nov 11.
  • Childs SK, Chen YH, Duggan MM, Golshan M, Pochebit S, Punglia RS, Wong JS, Bellon JR.Impact of Margin Status on Local Recurrence After Mastectomy for Ductal Carcinoma In Situ.Int J Radiat Oncol Biol Phys. 2012 Sep 10.
  • Margalit DN, Sreedhara M, Chen YH, Catalano PJ, Nguyen PL, Golshan M, Overmoyer BA, Harris JR, Brock JE.Microinvasive Breast Cancer: ER, PR, and HER-2/neu Status and Clinical Outcomes after Breast-Conserving Therapy or Mastectomy.Ann Surg Oncol. 2012 Sep 7.
  • Dominici L, Liao GS, Brock J, Iglehart JD, Lotfi P, Meyer J, Pandalai P, Golshan M.Large Needle Core Biopsy of Atypical Ductal Hyperplasia: Results of Surgical Excision.Breast J. 2012 Aug 17.
  • Hu YY, Weeks CM, In H, Dodgion CM, Golshan M, Chun YS, Hassett MJ, Corso KA, Gu X, Lipsitz SR, Greenberg CC.Impact of neoadjuvant chemotherapy on breast reconstruction.Cancer. 2011 Jan 24.
  • Bafford A, Gadd M, Gu X, Lipsitz S, Golshan M.Diminishing morbidity with the increased use of sentinel node biopsy in breast carcinoma.Am J Surg. 2010 Sep;200(3):374-7.
  • Javid S, Segara D, Lotfi P, Raza S, Golshan M.Can Breast MRI Predict Axillary Lymph Node Metastasis in Women Undergoing Neoadjuvant Chemotherapy.Ann Surg Oncol. 2010 Jul;17(7):1841-6.
  • Chun YS, Verma K, Rosen H, Lipsitz SR, Breuing K, Guo L, Golshan M, Grigorian N, Eriksson E.Use of tumescent mastectomy technique as a risk factor for native breast skin flap necrosis following immediate breast reconstruction.Am J Surg. 2010 Apr 19.
  • Garber JE, Golshan M.Contralateral breast cancer in BRCA1/BRCA2 mutation carriers: the story of the other side.J Clin Oncol. 2009 Dec 10;27(35):5862-4.
  • Ahmadiyeh N,Stoleru MA,Raza S,Lester SC,Golshan M.Management of Intraductal Papillomas of the Breast: An Analysis of 129 Cases and Their Outcome.Ann Surg Oncol. 2009 Aug;16(8):2264-9.
  • Ligibel JA,Partridge A,Giobbie-Hurder A,Golshan M,Emmons K,Winer EP.Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ.Ann Surg Oncol. 2009 Jan;16(1):106-12.
  • Barkley CR,Ligibel JA,Wong JS,Lipsitz S,Smith BL,Golshan M.Mucinous breast carcinoma: a large contemporary series.Am J Surg. 2008 Oct;196(4):549-51.
  • Javid SH,Smith BL,Mayer E,Bellon J,Murphy CD,Lipsitz S,Golshan M.Tubular carcinoma of the breast: results of a large contemporary series.Am J Surg. 2009 May;197(5):674-7.
  • Chen RC,Lin NU,Golshan M,Harris JR,Bellon JR.Internal mammary nodes in breast cancer: diagnosis and implications for patient management -- a systematic review.J Clin Oncol. 2008 Oct 20;26(30):4981-9. Review.
  • Partridge A,Winer JP,Golshan M,Bellon JR,Blood E,Dees EC,Sampson E,Emmons KM,Winer E.Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ.Clin Breast Cancer. 2008 Jun;8(3):275-80.
  • Bafford AC,Burstein HJ,Barkley CR,Smith BL,Lipsitz S,Iglehart JD,Winer EP,Golshan M.Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival.Breast Cancer Res Treat. 2009 May;115(1):7-12. Review.
  • Katz A, Smith BL, Golshan M, Niemierko A, Kobayashi W, Raad RA, Kelada A, Rizk L, Wong JS, Bellon JR, Gadd M, Specht M, Taghian AG.Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer.J Clin Oncol. 2008 May 1;26(13):2093-8.
  • Greenberg CC, Bafford AC, Golshan M.Is axillary dissection needed in node-positive breast cancer?.Expert Rev Anticancer Ther. 2008 Feb;8(2):195-8.
  • Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K, Winer E.Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.Journal of the National Cancer Institute. 2008 Feb 20;100(4):243-51.
  • Golshan M, Rusby J, Dominguez F, Smith BL.Breast conservation for male breast carcinoma.Breast. 2007 Dec;16(6):653-6.
  • Segara D, Krop IE, Garber JE, Winer E, Harris L, Bellon JR, Birdwell R, Lester S, Lipsitz S, Iglehart JD, Golshan M.Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?.J Surg Oncol. 2007 Nov 1;96(6):474-80.
  • Dominguez FJ, Golshan M, Black DM, Hughes KS, Gadd MA, Christian R, Lesnikoski BA, Specht M, Michaelson J, Smith BL.Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ.Ann Surg Oncol. 2008 Jan;15(1):268-73.
  • Carlson JW, Birdwell RL, Gombos EC, Golshan M, Smith DN, Lester SC.MRI-directed, wire-localized breast excisions: incidence of malignancy and recommendations for pathologic evaluation.Hum Pathol. 2007 Dec;38(12):1754-9.
  • Javid SH, Carlson JW, Garber JE, Birdwell RL, Lester S, Lipsitz S, Golshan M.Breast MRI wire-guided excisional biopsy: specimen size as compared to mammogram wire-guided excisional biopsy and implications for use.Ann Surg Oncol. 2007 Dec;14(12):3352-8.
  • Rusby JE, Smith BL, Dominguez FJ, Golshan M.Sentinel lymph node biopsy in men with breast cancer: a report of 31 consecutive procedures and review of the literature.Clin Breast Cancer. 2006 Dec;7(5):406-10. Review.
  • Golshan M, Smith B.Prevention and management of arm lymphedema in the patient with breast cancer.J Support Oncol. 2006 Sep;4(8):381-6. Review.
  • Golshan M, Nakhlis F.Can methylene blue only be used in sentinel lymph node biopsy for breast cancer?.Breast J. 2006 Sep-Oct;12(5):428-30.
  • Golshan M, Kuten A, William J, Richardson A, Modarressi A, Matulonis U.Metaplastic carcinoma of the breast with neuroglial differentiation.Breast. 2006 Aug;15(4):545-9.
  • Golshan M, Miron A, Nixon AJ, Garber JE, Cash EP, Iglehart JD, Harris JR, Wong JS.The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy.Am J Surg. 2006 Jul;192(1):58-62.
  • Golshan M, Lesnikoski BA, Lester S.Sentinel lymph node biopsy for occult breast cancer detected during breast reduction surgery.Am Surg. 2006 May;72(5):397-400.
  • Golshan M, Fung BB, Wiley E, Wolfman J, Rademaker A, Morrow M.Prediction of breast cancer size by ultrasound, mammography and core biopsy.Breast. 2004 Aug;13(4):265-71.
  • Golshan M, Fung BB, Wolfman J, Rademaker A, Morrow M.The effect of ipsilateral whole breast ultrasonography on the surgical management of breast carcinoma.Am J Surg. 2003 Oct;186(4):391-6.
  • Christein JD, Kim AW, Golshan MA, Maxhimer J, Deziel DJ, Prinz RA.Central pancreatectomy for the resection of benign or low malignant potential neoplasms.World J Surg. 2003 May;27(5):595-8.
  • Golshan M, Martin WJ, Dowlatshahi K.Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection.Am Surg. 2003 Mar;69(3):209-11; discussion 212.
  • Kim AW, Cacciopo JR, Golshan MA, Templeton AC, Prinz RA.Pancreatic epithelial cyst in an adult treated by central pancreatectomy.J Gastrointest Surg. 2001 Nov-Dec;5(6):634-7.
  • Golshan MM, McHenry CR, de Vente J, Kalajyian RC, Hsu RM, Tomashefski JF.Acute suppurative thyroiditis and necrosis of the thyroid gland: a rare endocrine manifestation of acquired immunodeficiency syndrome.Surgery. 1997 May;121(5):593-6.